Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China

Virology Journal

Volumn 9, Issue , 2012, Pages

  Ji, Hong ^a   Li, Liang ^a   Liu, Yanming ^b   Ge, Hengming ^c   Wang, Xushan ^d   Hu, Jianli ^a   Wu, Bin ^a   Fu, Jianguang ^a   Zhang, Zhenyu ^c   Chen, Xiaoqin ^c   Zhang, Minglei ^c   Ding, Qiang ^d   Xu, Wenbo ^b   Tang, Fenyang ^a   Zhou, Minghao ^a   Wang, Hua ^a   Zhu, Fengcai ^a  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Donghai County Center for Disease Control and Prevention   (China)

^d Ganyu Center for Disease Control and Prevention   (China)

Author keywords

CoxsackievirusA16; Hand, foot and mouth disease; Human enterovirus71; Maternally acquired immunity; Neutralizing antibody; Seroepidemiology

Indexed keywords

MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; CHILD; CHINA; CORRELATION ANALYSIS; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; COXSACKIE VIRUS INFECTION; CROSS-SECTIONAL STUDY; CYTOPATHOGENIC EFFECT; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; HAND FOOT AND MOUTH DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PRENATAL PERIOD; PRESCHOOL CHILD; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE;

ADOLESCENT; AGE FACTORS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; ENTEROVIRUS A, HUMAN; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES;

HUMAN ENTEROVIRUS 71; HUMAN ENTEROVIRUS A;

EID: 84867900517     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-248     Document Type: Article

References (39)

1. Human Enterovirus 71 Disease in Sarawak, Malaysia: A Prospective Clinical, Virological, and Molecular Epidemiological Study. Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, Mohan A, Chieng CH, Perera D, Clear D, Wong D, Blake E, Cardosa J, Solomon T, Clin Infect Dis 2007 44 646 656 10.1086/511073 17278054
2. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Bible JM, Pantelidis P, Chan PK, Tong CY, Rev Med Virol 2007 17 371 379 10.1002/rmv.538 17487831 (Pubitemid 350144562)
3. Complete Genome Analysis of Enterovirus 71 Isolated from an Outbreak in Taiwan and Rapid Identification of Enterovirus 71and Coxsackievirus a16 by RT-PCR. Yan JJ, Su IJ, Chen PF, Liu CC, Yu CK, Wang JR, J Med Virol 2001 65 331 339 10.1002/jmv.2038 11536241 (Pubitemid 32816704)
4. Comparison of enterovirus71, coxsackie-virusA16 clinical illnesses during the Taiwan enterovirus epidemic. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW, Kang CM, Pediatr Infect Dis J 1999 18 1092 1096 10.1097/00006454-199912000-00013 10608631
5. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. Yang KD, Yang MY, Li CC, Lin SF, Chong MC, Wang CL, Chen RF, Lin TY, J Infect Dis 2001 183 850 856 10.1086/319255 11237800 (Pubitemid 32207052)
6. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Chang LY, Hsiung CA, Lu CY, Lin TY, Huang FY, Lai YH, Chiang YP, Chiang BL, Lee CY, Huang LM, Pediatr Res 2006 60 466 471 10.1203/01.pdr.0000238247.86041.19 16940249 (Pubitemid 44427602)
7. Enterovirus infections and enterovirus specific T-cell responses in infancy. Juhela S, Hyöty H, Lönnrot M, Roivainen M, Simell O, Ilonen J, J Med Virol 1998 54 226 232 10.1002/(SICI)1096-9071(199803)54:3<226::AID- JMV14>3.0.CO;2-F 9515773 (Pubitemid 28102815)
8. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Yang C, Deng C, Wan J, Zhu L, Leng Q, Virol J 2011 8 306 10.1186/1743-422X-8-306 21679417
9. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ, J Biomed Sci 2000 7 523 528 10.1007/BF02253368 11060501
10. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Foo DG, Alonso S, Chow VT, Poh CL, Microbes Infect 2007 9 1299 1306 10.1016/j.micinf.2007.06. 002 17890123 (Pubitemid 47539204)
11. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. Wu TC, Wang YF, Lee YP, Wang JR, Liu CC, Wang SM, Lei HY, Su IJ, Yu CK, J Virol 2007 81 10310 10315 10.1128/JVI.00372-07 17626076 (Pubitemid 47463306)
12. Seroepidemiology of Human Enterovirus 71, Singapore. Ooi EE, Phoon MC, Ishak B, Chan SH, Emerg Infect Dis 2002 8 995 997 10.3201/eid0809.010397 12194783 (Pubitemid 35000825)
13. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Rabenau HF, Richter M, Doerr HW, Med Microbiol Immunol 2010 199 45 51 10.1007/s00430-009-0133-6 19941005
14. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City. Tran CB, Nguyen HT, Phan HT, Tran NV, Wills B, Farrar J, Santangelo JD, Simmons CP, Viet Nam. PLoS One 2011 6 21116
15. Enterovirus 71 maternal antibodies in infants, Taiwan. Luo ST, Chiang PS, Chao AS, Liou GY, Lin R, Lin TY, Lee MS, Emerg Infect Dis 2009 15 581 584 19331737
16. Neutralizing antibodies to enterovirus 71 in Belem, Brazil. Gomes Mde L, de Castro CM, Oliveira MJ, da Silva EE, Mem Inst Oswaldo Cruz 2002 97 47 49 12426594 (Pubitemid 135746202)
17. Seroepidemiology of enterovirus 71 among healthy children near Tokyo. Hagiwara A, Tagaya I, Komatsu T, Microbiol Immunol 1979 23 121 124 223018 (Pubitemid 9160447)
18. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z, Jiang X, Ji Y, Zhang Y, Xu W, Virol J 2010 7 300 10.1186/1743-422X-7-300 21050463
19. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Chiu CH, Chu C, He CC, Lin TY, Microbes Infect 2006 8 1671 1678 10.1016/j.micinf.2006.01.021 16815726 (Pubitemid 44128870)
20. Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants. Mao QY, Liao XY, Yu X, Li N, Zhu FC, Zeng Y, Liang ZL, Li FX, Wang JZ, Lu FM, Zhuang H, Chin Med J (Engl) 2010 123 1679 1684
21. Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09. Lee MS, Chiang PS, Luo ST, Huang ML, Liou GY, Tsao KC, Lin TY, PLoS Negl Trop Dis 2012 6 1476 10.1371/journal.pntd. 0001476 22348156
22. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, Chang HJ, Lin TY, Pediatrics 2002 109 88 10.1542/peds.109.6.e88 12042582
23. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Diedrich S, Weinbrecht A, Schreier E, Arch Virol 2009 154 1139 1142 10.1007/s00705-009-0413-x 19506798
24. Molecular and seroepidemiologic studies of enterovirus 71 infection in the State of Para, Brazil. Castro CM, Cruz AC, Silva EE, Gomes Mde L, Rev Inst Med Trop São Paulo 2005 47 65 71 (Pubitemid 40655654)
25. Enterovirus 71: the virus, its infections and outbreaks. Ho M, J Microbiol Immunol Infect 2000 33 205 216 11269363 (Pubitemid 32046397)
26. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. Lu CY, Lee CY, Kao CL, Shao WY, Lee PI, Twu SJ, Yeh CC, Lin SC, Shih WY, Wu SI, Huang LM, J Med Virol 2002 67 217 223 10.1002/jmv.2210 11992582 (Pubitemid 34493435)
27. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT, Ann Acad Med Singapore 2009 38 106 112 19271036
28. Development of enterovirus 71 vaccines. Lee MS, Chang LY, Expert Rev Vaccines 2010 9 149 156 10.1586/erv.09.152 20109026
29. Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71. http://clinicaltrials.gov/ct2/ show/NCT01376479
30. A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine. http://clinicaltrials.gov/ct2/show/NCT01268787
31. A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants. http://clinicaltrials.gov/ct2/show/ NCT01391494
32. A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants. http://clinicaltrials.gov/ct2/show/NCT01313715
33. Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children. http://clinicaltrials.gov/ct2/show/NCT01273246
34. Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults. http://clinicaltrials.gov/ct2/show/NCT01273233
35. A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children. http://clinicaltrials.gov/ct2/show/ NCT01267903
36. Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants. http://clinicaltrials.gov/ct2/show/NCT01421121
37. A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants. http://clinicaltrials.gov/ct2/show/ NCT01399853
38. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, Cheng AL, Fan TY, Chi H, Chang LY, J Microbiol Immunol Infect 2011 in press
39. Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. Hsu CH, Lu CY, Shao PL, Lee PI, Kao CL, Chung MY, Chang LY, Huang LM, J Microbiol Immunol Infect 2011 44 265 273 10.1016/j.jmii.2011.01.029 21524954